Florian Gnehm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Florian Gnehm has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Bernhard Morell
Department of Gastroenterology and Hepatology, Stadtspital Zürich Triemli, Zürich, Switzerland
1 shared publication - Christoph Gubler
Clinic for Gastro-Enterology Stadtspital Zürich Zurich Switzerland
1 shared publication - Eva-Maria Kretschmer
Department of Radiation Oncology and Competence Centre for Palliative Care, University Hospital Zurich, Zurich, Switzerland
1 shared publication - Fritz Ruprecht Murray
Gastroenterology and Hepatology Unit, Stadtspital Zürich, Zürich, Switzerland
1 shared publication - Simon Bütikofer
Gastroenterology and Hepatology Unit, Luzerner Kantonsspital, Lucerne, Switzerland
1 shared publication - Valeria Schindler
Department of Gastroenterology and Hepatology Zurich University Hospital Zurich Switzerland
1 shared publication
Latest Publications
- 29 June 2022
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 25 (7) , 1132-1135
Permanent Tunneled Drainage of Ascites in Palliative Patients: Timing Needs Evaluation
Background: Treatment of refractory ascites remains challenging. We evaluated the safety and efficacy of permanent tunneled peritoneal catheters (PTPC) in this condition. Methods: We retrospectively analyzed consecutive patients in palliative situations in a tertiary referral center. Safety parameters, symptom relief, and survival were assessed. Results: Seventy patients were included from February 2012 to January 2021. Ninety percent had ascites due to malignancy, 10% due to end-stage liver disease. The technical procedure was successful in all cases; no deaths occurred. Procedure-related infections were rare and only observed in patients without peri-interventional antibiotics. Most patients experienced symptom relief (76%) and were satisfied with the device (83%). Survival after PTPC was relatively short (median 19 days). Discussion: PTPC is a safe option for refractory ascites in palliative settings with symptom relief in the majority of patients and should be considered early after onset of ascites. Periprocedural antibiotic prophylaxis may be considered to avoid procedure-related infections.
- 29 June 2022
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 25 (7) , 1132-1135
Permanent Tunneled Drainage of Ascites in Palliative Patients: Timing Needs Evaluation
Background: Treatment of refractory ascites remains challenging. We evaluated the safety and efficacy of permanent tunneled peritoneal catheters (PTPC) in this condition. Methods: We retrospectively analyzed consecutive patients in palliative situations in a tertiary referral center. Safety parameters, symptom relief, and survival were assessed. Results: Seventy patients were included from February 2012 to January 2021. Ninety percent had ascites due to malignancy, 10% due to end-stage liver disease. The technical procedure was successful in all cases; no deaths occurred. Procedure-related infections were rare and only observed in patients without peri-interventional antibiotics. Most patients experienced symptom relief (76%) and were satisfied with the device (83%). Survival after PTPC was relatively short (median 19 days). Discussion: PTPC is a safe option for refractory ascites in palliative settings with symptom relief in the majority of patients and should be considered early after onset of ascites. Periprocedural antibiotic prophylaxis may be considered to avoid procedure-related infections.